SEC Form D · filed March 29, 2024
Outlook Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Lawrence A. Kenyon · Iselin, NJExec · DirectorJeff R. Evanson · Iselin, NJExecC. R. Trenary · Iselin, NJExec · DirectorRandy H. Thurman · Iselin, NJDirectorJulia A. Haller · Iselin, NJDirectorAndong G. Huang · Iselin, NJDirectorYezan H. Haddadin · Iselin, NJDirectorFaisal G. Sukhtian · Iselin, NJDirectorGerd G. Auffarth · Iselin, NJDirectorJulian G. Gangolli · Iselin, NJDirectorKurt J. Hilzinger · Iselin, NJDirectorAlan Pierrot · Fresno, CADirectorGilles Lamarre · Ottawa, Ontario, CanadaExec · DirectorM. W. Macey, Jr · Greenwich, CTDirectorRajesh Sharma · Saint-Laurent, Quebec, CanadaDirectorJames Bracken · Schaumburg, ILDirectorJoseph J. Gault · Greenwich, CTDirectorMichael A. Barr · Greenwich, CTDirectorJeff R. Evanson · Iselin, NJExecMelvyn Reznick · Reno, NVExec · DirectorMark H. Barineau · Houston, TXDirectorLuke Terrell · Fayetteville, ARDirectorAvraham D. Dreyfuss · New York, NYDirectorMichael A. Scott · San Francisco, CADirectorAubrey Rankin · AUSTIN, TXDirectorDon Maniccia · AUSTIN, TXDirectorJared Hoffman · New York, NYDirectorNikolaos Perros · New York, NYDirectorLu Cai · New York, NYExec · DirectorXiao Jian Wang · New York, NYDirectorYun Zhang · New York, NYExec · DirectorLei Zhang · New York, NYDirectorMartin Steyn · Grand Cayman, Cayman IslandsExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗